Siemens Healthineers Uses Artificial Intelligence to Take X-Ray Diagnostics to a New Level

Siemens HealthineersSiemens Healthineers introduces Ysio X.pree(1), the world's first intelligent X-ray system with integrated AI for optimizing the daily routine of image acquisition in radiography. To assist radiologists with the subsequent image post-processing, Siemens Healthineers also offers its new CE-labeled AI-Rad Companion Chest X-ray, an AI-supported software that aids clinical decision making on upright thorax images. "X-rays are still the most commonly used form(2) of diagnostic imaging. By introducing AI technologies and other innovations into this area, we’re taking traditional radiography to a new level," says Carsten Bertram, Head of X-ray Products at Siemens Healthineers.

Ysio X.pree

The Red Dot Design Award winning Ysio X.pree helps prepare for X-ray image acquisition using AI. Based on the images from a 3D camera, the AI-based algorithm automatically detects the thorax and thus sets the optimal acquisition area for this - the so-called collimation. The radiation is focused only on the relevant area, and the goal is to acquire an image containing all the necessary information with the lowest possible radiation exposure. The user can make adjustments to the collimation area at any time on a live touch-screen image of the patient. AI functionality and other intelligent tools for image acquisition preparation are combined in the so-called myExam Companion. For full-spine and long-leg exposures, with the support of the live image of the 3D camera, the user can easily reduce the number of images needed and therefore reduce the dose.

These new functionalities allow the user to utilize the device optimally every time and to concentrate more on the patient. Dr. Matthias May, Chief Physician of Radiology, University Clinic Erlangen, who is currently working with the device, says: "Thanks to the intuitively designed user interface of the Ysio X.pree, it was possible from day one to cover a wide range of examinations with high-quality results, even without intensive training. With the programmable robotics, the individual flavor settings for the image impression, the support of myExam Companion and the AI supported 3D camera, a wide array of technical solutions for the personalization of examination procedures is available."

AI-Rad Companion Chest X-ray

DICOM X-rays images from devices such as Ysio X.pree are a very good basis for Siemens Healthineers’ new AI clinical decision support software: AI-Rad Companion Chest X-ray(3). The newest member of the AI-Rad Companion product family complements the solutions already available for CT and MRI. Using artificial intelligence, it examines Chest X-rays for abnormalities. The software acts as a kind of "concurrent reader" for example, highlighting nodules in the lungs or indicates the presence of a pneumothorax with confidence scores. AI-Rad Companion Chest X-ray is vendor agnostic and conforms with the DICOM standards. The entire AI-Rad Companion product family benefits from the teamplay digital health platform. Its secure cloud environment provides high computing power, so no additional hardware resources are needed on-site.

About Siemens Healthineers

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostic, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers ability to provide high-quality, efficient care to patients. In fiscal 2019, which ended on September 30, 2019, Siemens Healthineers, which has approximately 52,000 employees worldwide, generated revenue of €14.5 billion and adjusted profit of €2.5 billion.

1. YSIO X.pree and its features are not yet commercially available in all countries. Their future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.
2. "Diagnostic Imaging Dataset Annual Statistical Release 2018/19." NHS, S.6.
3. AI-Rad Companion Chest X-ray is not yet commercially available in all countries.

Most Popular Now

Open Call HORIZON-MISS-2022-CANCER-01-04…

The overall goal of the Mission on Cancer[1] and the Europe's Beating Cancer Plan[2] includes a better quality of life for patients and their families living with, and after, cancer. Project...

Researchers Use AI to Predict Cancer Ris…

An artificial intelligence (AI) tool helps doctors predict the cancer risk in lung nodules seen on CT, according to a new study published in the journal Radiology. Pulmonary nodules appear as...

Insilico Medicine Raises $60 Million in …

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has completed a $60 million Series D financing from a syndicate of global investors with...

Speech Analysis App Predicts Worsening H…

A voice analysis app used by heart failure patients at home recognises fluid in the lungs three weeks before an unplanned hospitalisation or escalation in outpatient drug treatment. The late...

Siemens Healthineers and Penta Hospitals…

Penta Hospitals International, the largest multi-national hospital chain in Central and Eastern Europe, agreed a strategic partnership with Siemens Healthineers valued at over 30 million euros. Penta Hospitals International operates...

Screening for Diabetic Retinopathy Prove…

Both telemedicine and community screening for diabetic retinopathy (DR) in rural and urban settings are cost-effective in China, and telemedicine screening programs are more cost-effective, according to a study led...

KTU Researchers Investigate the Links Be…

In recent years Alzheimer's disease has been on the rise throughout the world and is rarely diagnosed at an early stage when it can still be effectively controlled. Using artificial...

Researchers Develop Smartphone-Powered M…

A University of Minnesota Twin Cities research team has developed a new microfluidic chip for diagnosing diseases that uses a minimal number of components and can be powered wirelessly by...

Philips' Future Health Index 2022 Report…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the publication of its Future Health Index (FHI) 2022 report: 'Healthcare hits reset: Priorities shift as...

App Detecting Jaundice in Babies a Succe…

A smartphone app that identifies severe jaundice in newborn babies by scanning their eyes could be a life-saver in areas that lack access to expensive screening devices, suggests a study...

InterSystems Wins Data Driven Product of…

InterSystems, a provider of next-generation solutions for enterprise digital transformation to help customers solve the most critical data challenges, has announced it received the prestigious Data Driven Product of the...